Head to head
MiniMed Group vs Intuitive Surgical
Side-by-side on the measures that matter, with a plain-English read. Full detail: MMED · ISRG
MMED
MiniMed Group
16.01-1.54%
1-year price shape — not enough history yet
Quant Rating C · 0/100
vs
ISRG
Intuitive Surgical
399.05-2.01%
1-year price shape — -28% over the period
Quant Rating E · 15/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical has the highest Quant Rating (15); Intuitive Surgical earns the most per share.
| MMED | ISRG | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Instruments & Supplies | -- |
| Last price | 16.01 | 399.05 |
| Change today | -1.54% | -2.01% |
| 1-year return | -- | -27.7% |
| Market cap | $4.50B | $138.33B |
| 52-week range | 10.65 – 24.43 | 328.57 – 603.88 |
| Valuation | ||
| P/E (TTM) | -14.21 | 48.25 |
| P/E percentile, own 5-yr range | 34th | 16th |
| P/B | 1.24 | 8.65 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -1.30 | 7.87 |
| Net profit (TTM) | $-365.75M | $2.73B |
| Revenue (TTM) | $3.22B | $11.58B |
| Provider revenue period date | 2026-07-30 | 2026-09-29 |
| Revenue growth (YoY) | +16.6% | +21.7% |
| Gross margin | 53.9% | 67.2% |
| Operating margin | -5.0% | 32.3% |
| Net margin | -9.7% | 25.5% |
| Free cash flow (TTM) | $-316.00M | $3.60B |
| Provider cash-flow period date | 2026-07-30 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 29.1% | 86.7% |
| Insider activity (12mo) | 41 buy / 8 sell | 17 buy / 33 sell |
| Short interest (% of float) | 3.5% | 2.0% |
| Analyst consensus | 85% buy / 15% hold (13) | 100% buy (18) |
| Analyst price target | $26 (+65%) | $516 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | C (0) | E (15) |
| Company | ||
| Employees | 8,000 | 17,021 |
| Founded | 1983 | 1995 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.